These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1333352

  • 1. Inhibition of cardiac sarcolemmal Na+/H+ antiporter by opioids.
    Periyasamy SM.
    Can J Physiol Pharmacol; 1992 Jul; 70(7):1048-56. PubMed ID: 1333352
    [Abstract] [Full Text] [Related]

  • 2. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL, Nayanar V, Walker JS.
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Possible mechanism involved in the inhibitory action of U-50, 488H, an opioid kappa agonist, on guinea pig hippocampal CA3 pyramidal neurons in vitro.
    Iwama T, Ishihara K, Takagi H, Satoh M.
    J Pharmacobiodyn; 1987 Oct; 10(10):564-70. PubMed ID: 3326929
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interaction of U-50,488H with calcium channel agonists and antagonists in different cardiac tissues.
    Micol JA, Laorden ML.
    J Auton Pharmacol; 1992 Dec; 12(6):437-44. PubMed ID: 1282128
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of a kappa-receptor agonist, U-50,488H, on the release of endogenous brain dopamine.
    Clow DW, Jhamandas K.
    Can J Physiol Pharmacol; 1988 Feb; 66(2):128-33. PubMed ID: 2836044
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
    Zhang WM, Wang HX, Xia Q, Wong TM.
    Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
    Alcaraz C, Milanés MV, Vargas ML.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634
    [Abstract] [Full Text] [Related]

  • 20. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons.
    Ventura C, Spurgeon H, Lakatta EG, Guarnieri C, Capogrossi MC.
    Circ Res; 1992 Jan; 70(1):66-81. PubMed ID: 1309318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.